Patents by Inventor Douglas A. Fisher

Douglas A. Fisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for rapid severance of a decoy towline
    Patent number: 8387501
    Abstract: A method and apparatus for rapidly severing a decoy towline extending from an aircraft by a mechanical spring actuated cutting blade and a thermal fuse type of release mechanism eliminating a pyrotechnic actuation device. The cutting blade is biased toward cutting engagement with the towline by a preloaded coil compression spring retained in the loaded position by a length of a polymer cord. The polymer cord has a heater wire wrapped about a portion of the cord which is connected to a DC voltage supply. The heater wire melts the cords when electrically connected to the DC power supply which releases the restraint on the spring which then drives the cutting blade into severing engagement with the towline.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: March 5, 2013
    Assignee: BAE Systems Information and Electronic Systems Integration Inc.
    Inventors: James J. Jordan, Daniel J. Murphy, Douglas A. Fisher, Jr., Tyler Forbes
  • Method and apparatus for rapid severance of a decoy towline
    Publication number: 20100257983
    Abstract: A method and apparatus for rapidly severing a decoy towline extending from an aircraft by a mechanical spring actuated cutting blade and a thermal fuse type of release mechanism eliminating a pyrotechnic actuation device. The cutting blade is biased toward cutting engagement with the towline by a preloaded coil compression spring retained in the loaded position by a length of a polymer cord. The polymer cord has a heater wire wrapped about a portion of the cord which is connected to a DC voltage supply. The heater wire melts the cords when electrically connected to the DC power supply which releases the restraint on the spring which then drives the cutting blade into severing engagement with the towline.
    Type: Application
    Filed: April 10, 2009
    Publication date: October 14, 2010
    Applicant: BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC.
    Inventors: James J. Jordan, Daniel J. Murphy, Douglas A. Fisher, JR., Tyler Forbes
  • Human phosphodiesterase IV isozymes
    Patent number: 7138495
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences. This invention also relates to an assay method for detecting the presence of such novel isozymes in human cells, and to a method of identifying compounds or other substances that inhibit or modify the activity of such isozymes.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: November 21, 2006
    Assignee: Pfizer Inc.
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Human phosphodiesterase IV isozymes
    Patent number: 7087734
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences. This invention also relates to an assay method for detecting the presence of such novel isozymes in human cells, and to a method of identifying compounds or other substances that inhibit or modify the activity of such isozymes.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: August 8, 2006
    Assignee: Pfizer, Inc.
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Method and apparatus for managing incident reports
    Patent number: 7051244
    Abstract: Incident report management is provided for managing received incident reports in an enterprise environment. The incident report management includes a correlator configured to determine whether a received incident report correlates with a previously received incident report, wherein received incident reports of new incidents are forwarded to a response queue.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: May 23, 2006
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Douglas A. Fisher, Eric W. Loy
  • Human phosphodiesterase IV isozymes
    Patent number: 6914133
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences. This invention also relates to an assay method for detecting the presence of such novel isozymes in human cells, and to a method of identifying compounds or other substances that inhibit or modify the activity of such isozymes.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: July 5, 2005
    Assignee: Pfizer Inc.
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Cyclic GMP phosphodiesterase
    Patent number: 6858714
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: February 22, 2005
    Assignee: Incyte Corporation
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Method and apparatus for managing incident reports
    Publication number: 20040153693
    Abstract: Incident report management is provided for managing received incident reports in an enterprise environment. The incident report management includes a correlator configured to determine whether a received incident report correlates with a previously received incident report, wherein received incident reports of new incidents are forwarded to a response queue.
    Type: Application
    Filed: October 31, 2002
    Publication date: August 5, 2004
    Inventors: Douglas A. Fisher, Eric W. Loy
  • Novel human phosphodiesterase IV isozymes
    Publication number: 20040073020
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences.
    Type: Application
    Filed: November 7, 2003
    Publication date: April 15, 2004
    Applicant: Pfizer Inc.
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Novel human phosphodiesterase IV isozymes
    Publication number: 20040073019
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences.
    Type: Application
    Filed: November 7, 2003
    Publication date: April 15, 2004
    Applicant: Pfizer Inc.
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Novel human phosphodiesterase IV isozymes
    Publication number: 20040038208
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences.
    Type: Application
    Filed: June 6, 2002
    Publication date: February 26, 2004
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Cyclic nucleotide phosphodiesterase
    Publication number: 20040018605
    Abstract: 99 The invention provides human cyclic nucleotide phosphodiesterases (PDE8) and polynucleotides which identify and encode PDE8. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE8.
    Type: Application
    Filed: July 25, 2003
    Publication date: January 29, 2004
    Applicant: Incyte Corporation
    Inventors: Janice Au-Young, Benjamin G. Cocks, Roger Coleman, Jeffrey J. Seilhamer, Douglas A. Fisher
  • Antibodies specifically binding PDE8A and PDE8B
    Publication number: 20030139578
    Abstract: The invention provides a antibody that specifically binds human PDE8s and is used to diagnose, stage and treat prostate cancer.
    Type: Application
    Filed: October 15, 2002
    Publication date: July 24, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Janice K. Au-Young, Benjamin G. Cocks, Roger T. Coleman, Jeffrey J. Seilhamer, Douglas A. Fisher
  • Human phosphodiesterase IV isozymes
    Patent number: 6489457
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences. This invention also relates to an assay method for detecting the presence of such novel isozymes in human cells, and to a method of identifying compounds or other substances that inhibit or modify the activity of such isozymes.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: December 3, 2002
    Assignee: Pfizer Inc
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Cyclic GMP phosphodiesterase
    Publication number: 20020007046
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Application
    Filed: March 8, 2001
    Publication date: January 17, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Screening novel human phosphodiesterase IV isozymes for compounds which modify their enzymatic activity
    Patent number: 6323041
    Abstract: This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences. This invention also relates to an assay method for detecting the presence of such novel isozymes in human cells, and to a method of identifying compounds or other substances that inhibit or modify the activity of such isozymes.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 27, 2001
    Assignee: Pfizer Inc.
    Inventors: Douglas A. Fisher, Michael D. Robbins
  • Cyclic GMP phosphodiesterase
    Patent number: 6255456
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: July 3, 2001
    Assignee: Incyte Genomics, Inc.
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter
  • Cyclic nucleotide phosphodiesterases
    Patent number: 6080548
    Abstract: The invention provides human cyclic nucleotide phosphodiesterases (PDE8) and polynucleotides which identify and encode PDE8. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE8.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: June 27, 2000
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Janice Au-Young, Benjamin G. Cocks, Roger Coleman, Jeffrey J. Seilhamer, Douglas A. Fisher
  • Cyclic nucleotide phosphodiesterases
    Patent number: 5932423
    Abstract: The invention provides human cyclic nucleotide phosphodiesterases (PDE8) and polynucleotides which identify and encode PDE8. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE8.
    Type: Grant
    Filed: November 19, 1997
    Date of Patent: August 3, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Janice Au-Young, Benjamin G. Cocks, Roger Coleman, Jeffrey J. Seilhamer, Douglas A. Fisher
  • Cyclic GMP phosphodiesterase
    Patent number: 5922595
    Abstract: The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and polynucleotides which identify and encode PDE9A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE9A.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: July 13, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Douglas A. Fisher, Douglas H. Gooding, David Gray Streeter